Dariohealth reports third quarter 2021 results and operational highlights

New york, nov. 15, 2021 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 and provided a corporate and commercial update. "the third quarter provided the strongest validation yet of our strategy of building one of the broadest multi-chronic condition digital health platforms in the industry," stated erez raphael, chief executive officer of dario.
DRIO Ratings Summary
DRIO Quant Ranking